Opium use and COVID-19 infection, a retrospective study in Iran
DOI:
https://doi.org/10.26641/2307-0404.2022.3.265958Keywords:
opium, addiction, Covid-19Abstract
The situation of Covid-19 patients with opium consumption has not been comprehensively investigated especially in Iran. This study is aimed to investigate the effect of current opium addiction on the severity and outcome of the Covid-19 infection. During a retrospective cohort study, clinical, demographic and all variables related to the severity and death due to the Corona virus infection were collected from the medical records of patients hospitalized from February 2020 to June 2021 in the study area. The role of current addiction in the severity and outcome of the disease was investigated using Cox, logistic and linear regression models. Of 939 confirmed Covid-19 cases admitted during the study period, 70 (7.5%) patients were currently addicted. Multivariate regression models showed that current opium addiction significantly increased the chance of endotracheal intubation (OR=2.96, p=0.005) and reduced the mean length of stay in hospital (beta coefficient =-0.42, p<0.0001). However, opium addiction did not change the risk of death (HR= 1.54, p=0.063) or O2 saturation (OR=1, p>0.99). Opium addiction can be associated with the severity of Covid-19 infection, but does not play a considerable role in the mortality of the patients.
References
Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrobe Agents. 2020;55(3):105924. doi: https://doi.org/10.1016/j.ijantimicag.2020.105924
Farhoudian A, Baldacchino A, Clark N, Gerra G, Ekhtiari H, Dom G, et al. COVID-19 and substance use disorders: Recommendations to a comprehensive health-care response. An International Society of Addiction Medicine Practice and Policy Interest Group Position Paper. Basic Clin Neurosci. 2020;11(2):133-50. doi: https://doi.org/10.32598/bcn.11.covid19.1
Saeedi M, Omrani-Nava V, Maleki I, Hedayati-zadeh-Omran A, Ahmadi A, Moosazadeh M, et al. Opium Addiction and COVID-19: Truth or false beliefs. Iran J Psychiatry Behav Sci. 2020;14(2):e103509. doi: https://doi.org/10.5812/ijpbs.103509
Irwin A, Valentine N, Brown C, Loewenson R, Solar O, Brown H, et al. The commission on social deter-minants of health: Tackling the social roots of health inequities. PloS Med. 2006;3(6):e106. doi: https://doi.org/10.1371/journal.pmed.0030106
Babaei HA, Ramezankhani A, Barekati H, Vejdani M, Shariatinejad K, Panahi R, et al. Prevalence of sub¬stance abuse among dormitory students of Shahid Beheshti University of Medical Sciences, Tehran, Iran. Int J High Risk Behav Addict. 2015;4(2):e22350. doi: https://doi.org/10.5812/ijhrba.22350v2
Aflatoonian MR, Sharifi I, Aflatoonian B, Divsalar K. Changes in the pattern of opium addiction in Bam after the earthquake. Report of Health Care. 2015;1(3):104-8.
Ziaee M, Hajizadeh R, Khorrami A, Sepehrvand N, Momtaz S, Ghaffari S. Cardiovascular complica-tions of chronic opium consumption: A narrative review article. Iran J Public Health. 2019;48(12):2154-64. doi: https://doi.org/10.18502/ijph.v48i12.3546
Dubey S, Biswas P, Ghosh R, Chatterjee S, Dubey MJ, Chatterjee S, et al. Psychosocial impact of COVID-19. Diabetes Metab Syndr. 2020;14(5):779-88. doi: https://doi.org/10.1016/j.dsx.2020.05.035
Nabati S, Asadikaram G, Arababadi MK, Shahabinejad G, Rezaeian M, Mahmoodi M, et al. The plasma levels of the cytokines in opium-addicts and the effects of opium on the cytokines secretion by their lymphocytes. Immunol Lett. 2013;152(1):42-6. doi: https://doi.org/10.1016/j.imlet.2013.04.003
Pirnia B, Dezhakam H, Pirnia K, Malekanmehr P, Soleimani AA, Zahiroddin A, et al. COVID-19 pandemic and addiction: Current problems in Iran. Asian J Psychiatr. 2020;54:102313. doi: https://doi.org/10.1016/j.ajp.2020.102313
Farhoudian A, Baldacchino A, Clark N, Gerra G, Ekhtiari H, Dom G, et al. COVID-19 and SubstanceUse Disorders: Recommendations to a Comprehensive Health¬care Response. An International Society of Addiction Medicine Practice and Policy Interest Group Position Paper. Basic Clin Neurosci. 2020;11(2):133-50. doi: https://doi.org/10.32598/bcn.11.covid19.1
Wang QQ, Kaelber DC, Xu R, Volkow ND. COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States. Molecular psychiatry. 2021 Jan;26(1):30-9. doi: https://doi.org/10.1038/s41380-020-00880-7
Dolati-Somarin A, Bahareh AN. The Reasons for Higher Mortality Rate in Opium Addicted Patients with COVID-19: A Narrative Review. Iranian Journal of Public Health. 2021 Mar;50(3):470. doi: https://doi.org/10.18502/ijph.v50i3.5587
Volkow ND. Collision of the COVID-19 and Addiction Epidemics. Ann Intern Med. 2020;173(1):61-62. doi: https://doi.org/10.7326/M20-1212
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Medicni perspektivi
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.